Infinium Global Research has published its latest report on “Allergy Vaccine Market (Allergy Type - Allergic Asthma, Peanut Hypersensitivity, Seasonal Allergic Rhinitis, Grass Pollen Hypersensitivity, Tree Pollen Hypersensitivity, Cat Dander Allergy, and Other Allergy Type; Vaccine Type - Cat Allergy Vaccine, Peanut Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Ragweed Allergy Immunotherapy Vaccine, and Other Vaccine Type): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025”. The report finds that the market is poised to grow at a healthy CAGR over the forecast period of 2019-2025.
Ask for Sample Copy of Research Report with Table of Content @ https://www.infiniumglobalresearch.com/reports/sample-request/15273
Allergy Vaccine Market: Drivers and Restraints
Allergy can occur due to food inject into the body or due to inhalation into the lungs. Common types of allergies include allergic asthma, drug allergy, food allergy, allergic rhinitis, etc. The key factors driving the growth of the market are growing prevalence of allergic diseases and new research activities for the development of allergy vaccines by private and government industries. However, high costs associated with the vaccines and the presence of limited manufacturers can restrain the growth of the market. Nonetheless, the market is expected to generate substantial demand opportunities during the forecast period due to rising awareness about the allergy disease and their treatment among the people globally.
Allergy Vaccine Market: Segmentation
The report gives an in-depth analysis of the global allergy vaccine market, focuses on market opportunities, along with the trends driving the market. The report on the global allergy vaccine market covers segments such as allergy type and vaccine type.
Request a Discount on Standard Prices of this Premium Report @ https://www.infiniumglobalresearch.com/reports/request-discount/15273
Based on allergy type, the sub-markets include allergic asthma, peanut hypersensitivity, seasonal allergic rhinitis, grass pollen hypersensitivity, tree pollen hypersensitivity, cat dander allergy, and other allergy types. Food allergy is one of the major forms of allergies. According to a report by Food Allergy Research and Education (FARE), peanuts caused the most number of allergies in the U.S., among all food allergens. Peanut allergy is very prevalent in the present scenario. Therefore the peanut allergy vaccine market will gain traction during the forecast period, thereby influencing the growth of the global allergy vaccine market. Bombay is a privately-owned medical company that is located in Austria. It has developed a grass pollen vaccine, which is known as BM32. They recently completed the second phase of the study. The immunotherapeutics specialists stated that the second phase of the study showed that subjects who received five monthly injections of BM32 noticed a significant improvement in their symptoms. The third phase of the trial will be starting soon and are hoping that the grass pollen vaccine will be available in the market by the year 2021. A Switzerland-based company revealed it’s developing a new vaccine for cat allergies that are administered directly to the animal instead of a person. Though, not yet available, the vaccine targets Fel d 1, a common feline allergen that collects in the animal’s fur.
Based on the vaccine type, the sub-markets include cat allergy vaccine, peanut allergy vaccine, house dust mite allergy vaccine, injectable MPL allergy vaccine, Ragweed allergy immunotherapy vaccine and other vaccine types. In May 2019, a British biotechnology company announced the Acarovac Monophosphoryl lipid A (MPL) immunotherapy improved dust mite allergy symptoms during a limited, phase 1 clinical study. Acarovac MPL is a subcutaneous immunotherapy product containing Dermatophagoides pteronyssinus and Dermatophagoides farinae allergoids, adsorbed to the adjuvant system comprised of MCT(R) (Microcrystalline Tyrosine) and MPL.
Allergy Vaccine Market: Competitive Analysis
Some of the major players in the market are Circassia, Cytos Biotechnology AG, DVB Technologies SA, Allertein Therapeutics, Stallergenes Greer plc, Merck & Co., Inc., Allergy Therapeutics, and Novartis International AG.
Read Detailed Index of full Research Study at https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-allergy-vaccine-market
Allergy Vaccine Market: Regional Insights
Geographically the allergy vaccine market is divided into North America, Europe, Asia- Pacific, and RoW. North America is expected to dominate the market in the forecast period, followed by Europe. Based on the report published by AAFA more than 50 million Americans are suffering from various types of allergies each year and it has become the 6th leading cause of chronic illness in the United States. Growing cases of allergy diseases in these regions will contribute to the high demand for allergy vaccines in the future period. The Asia Pacific region is the emerging market for the allergy vaccine market. Over the past few decades, there have been a global increase in asthma, allergic rhinitis and atopic dermatitis, followed by a rapid rise in food allergy. The prevalence and pattern of specific food allergies and food-induced anaphylaxis are quite distinct in Asia. Based on the stats provided by the Asia Pacific Association of Allergy (APAAACI) in Asia-Pacific, the prevalence of allergic rhinitis is variously reported as ranging from around 8–10% of the population in Korea to more than 50% among adults in Vietnam and Thailand.
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the allergy vaccine.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
No comments:
Post a Comment